FDA with Dr. Harpreet Singh

Episode
67
Soundcloud
Share

In this episode of Lung Cancer Considered, Dr. Stephen Liu sits down with guest Dr. Harpreet Singh from the FDA to discuss the agency’s oncology drug approval process.  The interview also covers how new drug approvals are handled in other countries.

Guest
Stephen Liu, MD
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Harpreet Singh
Harpreet Singh, MD

MD

Director of Division of Oncology 2
U.S. Food and Drug Administration (FDA).
Related ILCN article